Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System
Water Quality Monitoring

Water Quality Monitoring

View Detailed Analysis

Analytics Overview

13
Form 483s Issued
1
483s converted to WL
14
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Nov 2024
Dr. Reddy's Laboratories Limited (Unit II)
Drugs
25 Mar 2024
Novo Nordisk A/S
Drugs
09 Nov 2023
Shilpa Medicare Limited
Drugs
20 Oct 2023
Aqualex Co., Ltd.
Drugs
20 Oct 2023
Kilitch Healthcare India Limited
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Ralph M Bernstein, Biologist
2
0
Zachary Kraus, Senior Research Scientist
2
0
Lindsey J Brown, Senior Microbiologist
2
0
Maxwell Korang-Yeboah, Senior Staff Fellow
2
0
Arsen Karapetyan
1
0
TITLE/ COMPANY Issue Date Status Details
I observed on 11/18/2024 an alert message displayed on HPLC ID #QC-400
Dr. Reddy's Laboratories Limited (Unit II)
19 Nov 2024 Normal Justification: Failure to obtain and check water quality documentation leads to uncontrolled quality risks.
Excerpt: suppliers did not provide you with any documentation not limited to certificate of analyses.
View Details
The routine sample volume that is used to test for appropriate standards of quality
Novo Nordisk A/S
25 Mar 2024 Normal Justification: Observation points to insufficient sample volumes for water quality, directly relating to water quality monitoring.
Excerpt: The routine sample volume ... is insufficient to be representative of the capacity of the water systems.
View Details
Insufficient information has been provided to demonstrate that the water and water used for
Novo Nordisk A/S
25 Mar 2024 Normal Justification: The issue of microbial contamination directly relates to the adequacy of Water Quality Monitoring processes.
Excerpt: water used for drug substance (DS) purification is adequately controlled for total microbial counts.
View Details
The plumbing system contains defects that could contribute to the contamination of drug products.
Shilpa Medicare Limited
09 Nov 2023 Normal Justification: The observation clearly indicates issues with the water quality monitoring system, directly related to the absence of continuous sanitization and the existence of dead legs.
Excerpt: Your (b) (4) water and water (b) (4) loop do not have a step for continuous sanitization.
View Details
The (b) (4) system contains defects that could contribute to the contamination of drug products.
Aqualex Co., Ltd.
20 Oct 2023 Normal Justification: Water samples exceeding microbial limits indicate issues with routine water monitoring protocols.
Excerpt: Results exceeding your limit of (b) (4) cfu/mL were identified, but not addressed.
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.